Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of the experimental compound cP12 in adults with up to 10% total body surface…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• cP12

Snippet

Sponsor: Neomatrix Therapeutics, Inc. | Conditions: Thermal Burns | Phase 2 | Status: RECRUITING